Fig. 3: Outcomes based on MRD and remission status at the time of transplantation. | Bone Marrow Transplantation

Fig. 3: Outcomes based on MRD and remission status at the time of transplantation.

From: Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study

Fig. 3

a Overall Survival (OS) according to measurable residual disease (MRD) and complete remission (CR) status. b Disease-free survival (DFS) according to MRD and CR status. c Cumulative Incidence of Relapse (CIR) according to MRD and CR status.

Back to article page